1217896-33-7

Basic information

• Product Name: methyl 2-(4-{[4-(trifluoromethyl)-1,3-thiazol-2-yl]amino}phenyl)propanoate
• Synonyms: methyl 2-(4-{[4-(trifluoromethyl)-1,3-thiazol-2-yl]amino}phenyl)propanoate
• CAS NO: 1217896-33-7
• Molecular Weight: 330.331
• Mol File: 1217896-33-7.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: methyl 2-(4-{[4-(trifluoromethyl)-1,3-thiazol-2-yl]amino}phenyl)propanoate(CAS DataBase Reference)
• NIST Chemistry Reference: methyl 2-(4-{[4-(trifluoromethyl)-1,3-thiazol-2-yl]amino}phenyl)propanoate(1217896-33-7)
• EPA Substance Registry System: methyl 2-(4-{[4-(trifluoromethyl)-1,3-thiazol-2-yl]amino}phenyl)propanoate(1217896-33-7)

Safety Data

• Hazardous Substances Data: 1217896-33-7(Hazardous Substances Data)

Upstream product

• 431-35-6 3-bromo-1,1,1-trifluoroacetone 
• 1217896-31-5 methyl 2-[4-(carbamothioylamino)phenyl]propanoate 

Downstream Products

• 1217896-41-7 methyl 2-(4-{methyl[4-(trifluoromethyl)-1,3-thiazol-2-yl]amino}phenyl)propanoate 
• 1217896-34-8 methyl 2-(4-{(trifluoroacetyl)[4-(trifluoromethyl)-1,3-thiazol-2-yl]amino}phenyl)propanoate 
• 1217896-04-2 [(2S)-2-(4-{[4-(trifluoromethyl)-1,3-thiazol-2-yl]amino}phenyl)propanoic acid] 

Relevant articles and documents

2-aryl-propionic acids and derivatives and pharmaceutical compositions containing them

The present invention relates to (R,S) 2-aryl-propionic acids and derivatives, their single enantiomer (S) and to pharmaceutical compositions containing them, which are used in the prevention and treatment of tissue damage due to the exacerbated recruitment of polymorphonucleated neutrophils (PMN leukocytes) at inflammation sites. The present invention provides compounds for use in the treatment of transient cerebral ischemia, bullous pcmphigo, rheumatoid arthritis, idiopathic fibrosis, glomerulonephritis and damages caused by ischemia and reperfusion.